These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 14985168)

  • 1. DC-based immunotherapy of B-cell malignancies.
    Reichardt VL; Brossart P
    Cytotherapy; 2004; 6(1):62-7. PubMed ID: 14985168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current status of vaccination therapy for leukemias.
    Reichardt VL; Brossart P
    Curr Hematol Rep; 2005 Jan; 4(1):73-6. PubMed ID: 15610663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy of hematological malignancies using dendritic cells.
    Van de Velde AL; Berneman ZN; Van Tendeloo VF
    Bull Cancer; 2008 Mar; 95(3):320-6. PubMed ID: 18390412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine strategies to treat lymphoproliferative disorders.
    Radford KJ; Vari F; Hart DN
    Pathology; 2005 Dec; 37(6):534-50. PubMed ID: 16373232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine- and immune-based therapy in chronic lymphocytic leukemia.
    Le Dieu R; Gribben J
    Semin Oncol; 2006 Apr; 33(2):220-9. PubMed ID: 16616069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cells in vaccination therapies of human malignant disease.
    Reichardt VL; Brossart P; Kanz L
    Blood Rev; 2004 Dec; 18(4):235-43. PubMed ID: 15501552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic cell vaccines in melanoma: from promise to proof?
    Lesterhuis WJ; Aarntzen EH; De Vries IJ; Schuurhuis DH; Figdor CG; Adema GJ; Punt CJ
    Crit Rev Oncol Hematol; 2008 May; 66(2):118-34. PubMed ID: 18262431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DC in multiple myeloma immunotherapy.
    Turtle CJ; Brown RD; Joshua DE; Hart DN
    Cytotherapy; 2004; 6(2):128-37. PubMed ID: 15203989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapeutic strategies for the treatment of plasma cell malignancies.
    Treon SP; Raje N; Anderson KC
    Semin Oncol; 2000 Oct; 27(5):598-613. PubMed ID: 11049026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taming cancer by inducing immunity via dendritic cells.
    Palucka AK; Ueno H; Fay JW; Banchereau J
    Immunol Rev; 2007 Dec; 220():129-50. PubMed ID: 17979844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing dendritic cell-based immunotherapy for cancer.
    Zhong H; Shurin MR; Han B
    Expert Rev Vaccines; 2007 Jun; 6(3):333-45. PubMed ID: 17542749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cell vaccines for leukemia patients.
    Schmitt A; Hus I; Schmitt M
    Expert Rev Anticancer Ther; 2007 Mar; 7(3):275-83. PubMed ID: 17338648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hematology 2010].
    Dreyling M; Subklewe M; Braess J; Spiekermann K
    Dtsch Med Wochenschr; 2010 Jun; 135(25-26):1322-5. PubMed ID: 20556691
    [No Abstract]   [Full Text] [Related]  

  • 14. Accomplishments and perspectives of immunological interventions in lymphoproliferative disorders.
    Milosević DB
    J Exp Clin Cancer Res; 2004 Mar; 23(1):9-13. PubMed ID: 15149145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of DC-based vaccine for therapy of B-CLL patients. Comparison of two methods for enriching monocytic precursors.
    Kokhaei P; Adamson L; Palma M; Osterborg A; Pisa P; Choudhury A; Mellstedt H
    Cytotherapy; 2006; 8(4):318-26. PubMed ID: 16923607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cell-based immunotherapy.
    Osada T; Clay TM; Woo CY; Morse MA; Lyerly HK
    Int Rev Immunol; 2006; 25(5-6):377-413. PubMed ID: 17169781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological evaluation of vaccination of peptides derived from epithelial cancer-related antigens in two patients with hematological malignancy.
    Takedatsu H; Yoshimoto K; Okamura T; Yakushij K; Imamura R; Hashiguchi M; Seki R; Obata Y; Harada M; Yamada A; Yamana H; Sata M; Itoh K
    Int J Oncol; 2005 Jun; 26(6):1605-12. PubMed ID: 15870876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in dendritic-cell-based therapeutic vaccines for cervical cancer.
    Bellone S; Pecorelli S; Cannon MJ; Santin AD
    Expert Rev Anticancer Ther; 2007 Oct; 7(10):1473-86. PubMed ID: 17944571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cell vaccines in acute leukaemia.
    Duncan C; Roddie H
    Best Pract Res Clin Haematol; 2008 Sep; 21(3):521-41. PubMed ID: 18790453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cell-based immunotherapy for the treatment of hematological malignancies.
    Büchler T; Michalek J; Kovarova L; Musilova R; Hajek R
    Hematology; 2003 Apr; 8(2):97-104. PubMed ID: 12745659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.